Related Experiment Videos
Safety of intravenous immunoglobulin with regard to hepatitis C virus
1Laboratory of Plasma Derivatives, US Food and Drug Administration, Bethesda, Maryland, USA.
Clinical Therapeutics
|January 1, 1996
Abstract
No abstract available in PubMed .